D-Pharm Ltd.
CEO Alexander Kozak founded D-Pharm Ltd. in 1993. D-Pharm de-velops and de-livers biopharmaceuticals to treat a variety of diseases. The company focuses on discovery and development of lipid-based compounds used primarily against central nervous system disorders. Drugs currently approaching the market include treatments for epilepsy, bipolar disorder, and stroke. The company's pipeline also includes drugs intended to fight Alzheimer's disease, Parkinson's disease, psoriasis, bowel disease, and cancer. D-Pharm partners with other drug companies to bring its treatments to market.
Contact Details
Office Address
D-Pharm Ltd.
Kiryat Weizmann Science Park, Bldg. 7
P.O. Box 2313
Rehovot, Israel 76123
Phone: +972-8-938-5100
Fax: +972-8-930-0795
Executives
Chairman
Ruben Krupik
President, CEO, and Director
Alexander Kozak